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Introduction 
Over the last decade, deep brain stimulation (DBS) has emerged as a possible therapy for refractory 
epilepsy patients. Different intracerebral targets have been targeted, including remote network 
structures (e.g. the anterior thalamic nucleus, the centromedian thalamic nucleus, the subthalamic 
nucleus, the caudate nucleus and the cerebellum) and the ictal onset zone. The latter can be 
approached by either continuous or responsive stimulation. In this abstract we present our long-term 
results with continuous mesial temporal lobe (MTL) DBS for MTL epilepsy. 
Methods 
Since 2001, 11 patients with refractory MTL complex partial seizures with or without secondary 
generalisation underwent uni-or bilateral MTL DBS depending on seizure onset localisation as 
determined by invasive video-EEG monitoring. When unilateral MTL DBS failed to decrease 
seizures with >90% after 3 years of stimulation, a switch to bilateral MTL DBS was proposed. 
Results 
After a mean follow-up of 8.5 years, 3/11 patients are seizure free for > 36 months. 3/11 patient 
have a >90 % reduction in seizure frequency; 2/11 patients have a reduction in seizure frequency of 
50-90 %; 1/11 patient has a reduction in seizure frequency of 30-50%; two patients are considered 
non-responders. Patients with a focal unilateral ictal onset (4/11), all of them experiencing a > 90% 
seizure frequency reduction, responded better than those with a regional unilateral (5/11) or bilateral 
ictal onset (2/11). None of the patients reported permanent symptomatic side effects.  
Regarding the chronic stimulation protocol, 4 relevant assessments were made. 1) Augmenting 
output voltage mostly did not affect seizure frequency, but in three cases it did. 2) In 5/6 patients in 
whom unilateral DBS failed to decrease seizure frequency with >90% after 2.5 to 3 years, bilateral 
DBS was started resulting in improved seizure control in 3/5 patients (> 90% reduction or seizure 
free). 3) In 4/5 patients in whom day-night cycling (DBS off between 0 and 6 am) was introduced 
after a stable frequency reduction had been reached, this did not affect seizure frequency. 4) In 7 
patients, DBS was switched off during at least a month. This was associated with an immediate or 
delayed increased seizure frequency in 4/7 patients, did not affect seizure frequency in 2/7 patients 
and coincided with seizure freedom in 1/7 patient. 
Discussion 
This open study with an extended long-term follow-up demonstrates maintained efficacy of DBS in 
MTL structures for patients with refractory medial temporal lobe epilepsy. In >50% of patients, a 
seizure frequency reduction of at least 90% has been reached. Patients with unilateral focal ictal 
onset seem to respond best. After failure of unilateral DBS, bilateral stimulation can improve results 
and therefore should be considered. Weaknesses of this study include the open study design and – 
allthough until today no larger patient series has been published – the small number of patients. 
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